(Alliance News) - Stocks in London are set to open unchanged on Wednesday ahead the US Federal Reserve's interest rate decision later in the day and the Bank of England's decision on Thursday. Read More
(Alliance News) - Stocks in London are set to open higher on Tuesday, as markets in London return to action following a bank holiday for the state funeral of Queen Elizabeth II. Read More
(Alliance News) - The mood remained downbeat at the end of a sour week for global equities, after data dashed hopes that US inflation is easing fast enough to warrant less aggressive interest rate hikes by the Federal Reserve. Read More
(Alliance News) - AstraZeneca PLC on Friday said it received two recommendations for drug approvals in the EU, while a drug for blood disorder paroxysmal nocturnal haemoglobinuria met its primary endpoint in a phase three trial. Read More
(Alliance News) - Stocks in London are set to end a difficult week on a downbeat note after economic data raised the prospect of the Federal Reserve acting even more aggressively to tame inflation. Read More
(Alliance News) - AstraZenea PLC on Monday shared several positive developments for its oncology pipeline, which will be presented at the European Society for Medical Oncology Congress 2022 in Paris. Read More
(Alliance News) - AstraZeneca PLC and Merck & Co Inc on Friday said their cancer drug lynparza, or olaparib, showed positive overall survival data for patients with ovarian cancer in three phase III studies. Read More
(Alliance News) - Stocks in London are set to kick off the new week on the back foot, as Russia's move to stop gas deliveries to Europe is giving investors pause, amid growing fears of an energy crisis. Read More
(Alliance News) - AstraZeneca PLC on Tuesday said its Evusheld Covid-19 treatment was approved in Japan for prevention and treatment of symptomatic disease caused by SARS-CoV-2 infection. Read More
(Alliance News) - AstraZeneca PLC on Saturday said new data show its Farxiga "significantly" lowers the risk of cardiovascular death in patients with heart failure. Read More
(Alliance News) - AstraZeneca PLC on Thursday shared its latest regulatory successes in a key market, winning approvals for three treatments in Japan. Read More
(Alliance News) - AstraZeneca PLC on Wednesday announced it will provide new safety and efficacy data on several of its cancer drugs, purporting to show longer survival for cancer patients. Read More
